Personalized Medicine in Woman Lung Cancer: Crizotinib and Osimertinib Association to Overcome Osimertinib Resistance

Article de revue

Fanny Leenhardt, Marie Viala, Stephane Pouderoux, Pierre Boisselier et Xavier Quantin

Journal of Women's Health and Development, Vol.3(3)

2020

Indicateurs

1 Consultations de la notice

Titre: Personalized Medicine in Woman Lung Cancer: Crizotinib and Osimertinib Association to Overcome Osimertinib Resistance
Créateurs - sans rôle: Fanny Leenhardt
Marie Viala
Stephane Pouderoux
Pierre Boisselier
Xavier Quantin
Détails de publication: Journal of Women's Health and Development, Vol.3(3)
Identifiants: 99141169509311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article